EMD-50260

Single-particle
2.31 Å
EMD-50260
3D View Gallery
Deposition: 08/05/2024
Map released: 25/12/2024
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-50260

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9f9t summary report (pdf.gz) Map-9f9t FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

CryoEM structure of native Trypanosoma cruzi apo proteasome 20S subunit

EMD-50260

Single-particle
2.31 Å
EMD-50260
3D View Gallery
Deposition: 08/05/2024
Map released: 25/12/2024
Last modified: 08/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Trypanosoma cruzi
Sample: Proteasome 20S
Fitted models: 9f9t

Deposition Authors: Rowland P
Pharmacological and structural understanding of the Trypanosoma cruzi proteasome provides key insights for developing site-specific inhibitors.
Eadsforth TC, Torrie LS, Rowland P, Edgar EV, MacLean LM, Paterson C, Robinson DA, Shepherd SM, Thomas J, Thomas MG, Gray DW , Postis VLG , De Rycker M
(2024) J Biol Chem , 301 , 108049 - 108049
PUBMED: 39638245
DOI: doi:10.1016/j.jbc.2024.108049
ISSN: 1083-351X
ASTM: JBCHA3
Grant Support: